tiprankstipranks
Trending News
More News >
ADMA Biologics (ADMA)
NASDAQ:ADMA
US Market
Advertisement

ADMA Biologics (ADMA) Revenue

Compare
2,934 Followers

ADMA Biologics Revenue

ADMA Biologics had a revenue of 121.98M in the quarter ending Jun 30, 2025, with 6.26%. This bring the company's revenue in the last twelve months to 474.17M, Decreased 3.22%. In the fiscal year ending Dec 31, 2024, ADMA Biologics had annual revenue of 426.45M with 65.15% growth.
Revenue (ttm)
474.17M
Revenue Growth
43.58%
P/S Ratio
9.44
Revenue/Employee
$622,561
Employees
685
Market Cap
$4.03B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
426.45M168.24M+65.15%
Dec 31, 2023
258.21M104.14M+67.59%
Dec 31, 2022
154.08M73.14M+90.36%
Dec 31, 2021
80.94M38.72M+91.72%
Dec 31, 2020
42.22M12.87M+43.85%
Dec 31, 2019
29.35M12.36M+72.79%
Dec 31, 2018
16.99M-5.78M-25.37%
Dec 31, 2017
22.76M12.10M+113.49%
Dec 31, 2016
10.66M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis